Oxbridge Re (OXBR) Stock Price, News & Analysis

Company Overview

Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology. In addition, the company offers fractional aircraft ownership, jet card, aircraft brokerage, and charter service through its fleet of private aircraft. It distributes its products and solutions through reinsurance brokers. Oxbridge Re Holdings Limited was incorporated in 2013 and is headquartered in George Town, the Cayman Islands.

Key Stats

• Today's Range: $1.74 to $1.85
• 50-Day Range: $1.53 to $2.45
• 52-Week Range: $1.27 to $5.81
• Volume: 24,947 shs
• Average Volume: 86,409 shs
• Market Capitalization: $13.47 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.00
• Consensus Rating: Buy

Oxbridge Re Stock Analysis - MarketRank™

Oxbridge Re scored higher than 49% of companies evaluated by MarketBeat, and ranked 659th out of 921 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Oxbridge Re has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Oxbridge Re has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Oxbridge Re is -5.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oxbridge Re is -5.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Oxbridge Re has a P/B Ratio of 2.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.82% of the float of Oxbridge Re has been sold short.

Short Interest Ratio / Days to Cover

Oxbridge Re has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Oxbridge Re has recently decreased by 34.80%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oxbridge Re does not currently pay a dividend.

Dividend Growth

Oxbridge Re does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.82% of the float of Oxbridge Re has been sold short.

Short Interest Ratio / Days to Cover

Oxbridge Re has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Oxbridge Re has recently decreased by 34.80%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Oxbridge Re this week, compared to 2 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Oxbridge Re insiders have bought 53.47% more of their company's stock than they have sold. Specifically, they have bought $41,850.00 in company stock and sold $27,270.00 in company stock.

Percentage Held by Insiders

15.32% of the stock of Oxbridge Re is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 5.64% of the stock of Oxbridge Re is held by institutions.

OXBR Stock Analysis - Frequently Asked Questions

How have OXBR shares performed this year?

Oxbridge Re's stock was trading at $4.12 at the beginning of 2025. Since then, OXBR shares have decreased by 56.7% and is now trading at $1.7860.

How were Oxbridge Re's earnings last quarter?

Oxbridge Re Holdings Limited (NASDAQ:OXBR) issued its quarterly earnings data on Monday, May, 12th. The insurance provider reported ($0.02) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.02). The insurance provider earned $0.69 million during the quarter, compared to analyst estimates of $0.65 million. Oxbridge Re had a negative net margin of 143.80% and a negative trailing twelve-month return on equity of 41.78%.
Read the conference call transcript.

How do I buy shares of Oxbridge Re?

Shares of OXBR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Oxbridge Re own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxbridge Re investors own include Organigram Global (OGI), i3 Verticals (IIIV), Trade Desk (TTD), Ford Motor (F), NVIDIA (NVDA), Lucid Group (LCID) and PayPal (PYPL).

Company Calendar

• Last Earnings: 5/12/2025
• Today: 8/10/2025
• Next Earnings (Estimated): 8/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: INS - BROKERS
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:OXBR
• CIK: 1584831
• Web: www.oxbridgere.com
• Phone: (345) 749-7570
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Oxbridge Re: $5.00
• High Price Target: $5.00
• Low Price Target: $5.00
• Potential Upside/Downside: +180.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.30)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.73 million
• Net Margins: -143.80%
• Pretax Margin: -60.90%
• Return on Equity: -41.78%
• Return on Assets: -23.85%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 10.37
• Quick Ratio: 10.37

Sales & Book Value

• Annual Sales: $1.36 million
• Price / Sales: 9.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.68 per share
• Price / Book: 2.63

Miscellaneous

• Outstanding Shares: 7,443,000
• Free Float: 5,995,000
• Market Cap: $13.29 million
• Optionable: Not Optionable
• Beta: 1.62